Parkinson's Disease Clinical Trial
Official title:
Effects of Virtual Reality Augmented Balance Training for Postural Control in Patients With Parkinson's Disease
Background and Objective: Postural instability is common in patient with Parkinson's disease
(PD). The purpose of this study was to investigate the effects of virtual reality (VR)
balance training on sensory and cognitive domains of postural control.
Setting: Balance Performance Laboratory. Participants: A total of 42 patients (Hoehn and
Yahr stage II-III) were recruited and assigned into three groups randomly.
Intervention: Participants in the virtual reality (VR) group and conventional balance
training (CB) group received a 6 weeks balance training program. The control group (CG) did
not receive any training.
Outcome Measures: The sensory organization tests (SOT) of computerized dynamic posturography
with single and dual tasks (i.e. with backward subtraction of number) were examined pre-,
post-training and follow-up. The equilibrium score (ES) and sensory ratio were measured. The
verbal reaction time (VRT) was recorded.
Results: (1) Only VR significantly increased ES of SOT-6 (i.e., vestibular function at
visual and somatosensory conflicting condition) post-training more than CG post-training in
either single or dual task. (2) Only CB training significantly increased SOT-5 (i.e.,
vestibular function without visual conflict) and vestibular sensory ratio (i.e.,
SOT-5/SOT-1) more than CG post-training in either single or dual task. (3) (3) Neither VR
nor CB training reduced VRT significantly under six sensory conditions at post-training and
follow-up.
Conclusion: Both VR training and CB training can improve sensory organization for postural
control by enhancing utilization of vestibular information, but VR could enhance vestibular
function with conflicting proprioceptive and visual information under single and dual tasks
in patients with mild to moderate PD.
It is common that people who are diagnosed with idiopathic Parkinson disease (PD) experience
postural instability during daily activities.Recently, postural instability is suggested as
the underlying mechanism of falling in patients with PD. Therefore, how to improve postural
stability by balance training is an important issue for these patients.
Basal ganglia have been regarded to be predominantly involved in postural control. Several
studies suggested that the dysfunction of basal ganglia in patients with PD might play a
major role in postural instability. Furthermore, patients with PD might have impaired
utilization of sensory information by the basal ganglia.Computerized dynamic posturography
(CDP) has the Sensory Organization Test (SOT), which provides an objective assessment of the
main sensory systems (i.e., vision, proprioception and vestibular system) involved in
balance and stability. The role of sensory information under six conditions (i.e., eyes
open, eyes closed, sway vision, eyes open sway support, eyes closed sway support, and sway
vision sway support) has been studied in patients with PD by the SOT of computerized CDP.
Their study indicated that patients with PD demonstrated a significant reduction in sensory
integration of proprioception and vision, but no significant difference in vestibular
function, as compared to age-matched controls. One study showed that patients with PD had
visual dependence as an adaptive strategy partly compensating for the impaired
proprioception. However, the other study suggested that the cerebellum might be important
for sensory integration in patients with PD.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 |